Table 2

Univariate analysis comparing patients with and without functional dependence in training cohort

mRS (3–6)P value
Yes
(n=1037)
No
(n=1074)
Demographic characteristics
 Age (years)
  <60406 (39.2)498 (46.4) 0.001
  ≥60631 (60.8)576 (53.6)
 Male684 (66.0)737 (68.6)0.192
Medical history
 Ischaemic stroke102 (9.8)81 (7.5)0.061
 Ischaemic heart disease42 (4.1)34 (3.2)0.276
 Hypertension672 (64.8)690 (64.2)0.789
 Hyperlipidaemia20 (1.9)27 (2.5)0.362
 Diabetes101 (9.7)87 (8.1)0.186
Admission characteristics
 Prestroke mRS0 (0–0)0 (0–0)0.062
 SBP (mm Hg)
  <180628 (45.4)754 (54.6) <0.001
  ≥180409 (56.1)320 (43.9)
 Baseline NIHSS
  0–369 (6.7)501 (46.6) <0.001
  4–554 (5.2)222 (20.7)
  6–14468 (45.1)295 (27.5)
  15–40446 (43.0)56 (5.2)
 Deep location
  Yes882 (85.1)841 (78.3) <0.001
  No155 (14.9)233 (21.7)
 Volume of haematoma (mL)
  <30675 (65.1)988 (92.0) <0.001
  30–60271 (26.1)77 (7.2)
  >6091 (8.8)9 (0.8)
 IVH159 (15.3)78 (7.3) <0.001
Admission laboratory values
 White cell count >10×109/L420 (40.5)219 (20.4) <0.001
 Hb <120 g/L241 (23.2)179 (16.7) <0.001
 PLT <100×109/L71 (6.8)64 (6.0)0.405
 NLR >10338 (32.6)167 (15.5) <0.001
 ALT >40 U/L111 (10.7)94 (8.8)0.130
 AST >40 U/L167 (16.1)63 (5.9) <0.001
 GFR <90 mL/min/1.73 m2 468 (45.1)410 (38.2) 0.001
 UA >420 μmol/L202 (19.5)183 (17.0)0.147
 FBG ≥7.0 mmol/L437 (42.1)279 (26.0) <0.001
 INR ≥1.2121 (11.7)58 (5.4) <0.001
  • Categorical variables were presented as n (%).

  • P<0.05 was represented in bold type.

  • ALT, glutamic pyruvic transaminase; AST, aspartate aminotransferase; FBG, fasting blood glucose; GFR, glomerular filtration rate; Hb, haemoglobin; INR, international normalised ratio; IVH, intraventricular haemorrhage; mRS, modified Rankin ScaleNIHSS, National Institutes of Health Stroke Scale; NLR, neutrophil-lymphocyte ratio; PLT, platelet; SBP, systolic blood pressure; UA, uric acid.